News & Events

You are here

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s largest medical institution – The Asan Medical Center’s (AMC) Clinical Trial Center.

05/07/11

Novotech in new research collaboration: Biotechnology News

LEADING Australian contract clinical research company Novotech, Marine Biotechnology Australia and the University of Sydney are taking part in a new herpes research collaboration backed by the Academic Research Council (ARC).

05/07/11

TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence: selects Novotech

Multi-national Study to be Conducted by Novotech in Australia, New Zealand, and South Korea MOUNTAIN VIEW, California, and SYDNEY, Australia, May 16, 2011 /PRNewswire-iReach/ — TheraVida, Inc., a clinical stage biopharmaceutical company...

15/06/11

Herpes Zoster Novel Treatment Hope From Tasmanian Abalone Gets $1.2 Million Boost

Sydney, Australia, 23 May 2011 – Leading Australian contract clinical research company Novotech, Marine Biotechnology Australia Pty Ltd [MBA] and the University of Sydney today announced a new Herpes research collaboration backed by the Academic...

03/11/10

Australian Life Scientist

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal...

29/10/10

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

NOVOTECH INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT, ONCOMED PHARMACEUTICALS Sydney, Australia, 29 October 2010 – Novotech has announced initiation of three Phase Ib oncology trials at sites in Australia and New...

27/10/10

CIO

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support...

27/10/10

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Sydney, Australia – 27 October, 2010 News Facts Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s...

26/10/10

iTnews

Novotech runs clinical trials on Oracle. A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. Novotech has announced that it will license...

25/08/10

Trials In Focus

Inside Stories – Wide brief for cancer candidate. A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. The aim of all three trials is to...

25/08/10

Outsourcing Pharma

Podcast: Asia Pacific trial sector poised for continued growth, says Novotech The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to...

Pages